On March 11, 2010
Facet Biotech Has $722M That Says It Pays to Stand Up to Bullies
Facet Biotech had to put up with some patronizing, rather snippy statements from Biogen Idec during an attempted hostile takeover last fall. Here’s what Facet investors are thinking now thanks to a better offer from Abbott.
…
0 Comments